UnknownNot applicableNCT05133453

Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis

Studying Asbestos intoxication

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Cairo University
Principal Investigator: Marwa M Fouad, MD
Cairo University
Intervention: Pirfenidone(drug)
Enrollment: 40 enrolled
Eligibility: 18-60 years · MALE
Timeline: 2024 – 2026

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05133453 on ClinicalTrials.gov

Other trials for Asbestos intoxication

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT04016181
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
University of Edinburgh

See all trials for Asbestos intoxication →

← Back to all trials